Looks like you’re on the US site. Choose another location to see content specific to your location
Corza Medical Introduces World’s First Single-Use Kit for ROP Exams

Steffan Mortimer
Corza Medical Inc., a prominent global medical technology company, has unveiled the SensorTek™ ROP Kit, marking a significant advancement in neonatal eye care. This innovative single-use kit integrates a diagnostic lens, providing the first comprehensive solution for performing Retinopathy of Prematurity (ROP) exams, a critical condition affecting about 1.4 million premature infants annually. The launch coincides with World Prematurity Day 2025, emphasizing Corza Medical’s commitment to improving pediatric ophthalmological care.
ROP poses a severe risk to infants born at or before 32 weeks’ gestation, potentially leading to vision loss or blindness if untreated. The SensorTek™ ROP Kit, engineered for neonatal ophthalmology, consists of essential tools like a single-use pediatric speculum, ergonomic scleral depressor, and a 28D diagnostic lens tailored for infant retinal assessment. By enabling sterile, streamlined, and precise exams, this kit addresses cross-contamination concerns, thus allowing pediatric ophthalmologists to provide effective care swiftly. This innovation by Corza Medical aligns with the 2025 World Prematurity Day theme, reinforcing the company’s dedication to delivering cutting-edge solutions for the most vulnerable patients.
Corza Medical’s launch of the SensorTek™ ROP Kit is a transformative step in neonatal ophthalmology, offering an all-in-one, sterile solution for examining premature infants. As part of its mission to advance care for preterm babies, Corza ensures that pediatric ophthalmologists are equipped with the right tools to deliver optimal outcomes. This development underlines Corza’s leadership in surgical technology, poised to set new standards in infant eye care.
Stay informed
Receive the latest industry news, Tips and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard